Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain

Journal of Cellular Physiology

Volumn 227, Issue 3, 2012, Pages 1157-1167

  Kim, Nayoung ^a   Yoo, Jae Cheal ^a   Han, Jae Yoon ^a   Hwang, Eun Mi ^a,c   Kim, Yoon Sook ^a   Jeong, Eun Young ^a   Sun, Choong Hyun ^b   Yi, Gwan Su ^b   Roh, Gu Seob ^a   Kim, Hyun Joon ^a   Kang, Sang Soo ^a   Cho, Gyeong Jae ^a   Park, Jae Yong ^a   Choi, Wan Sung ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Apoptosis; Bcl XL; Clusterin

Indexed keywords

BH3 PROTEIN; CASPASE 3; CLUSTERIN; CYTOCHROME C; PROTEIN BAX; SECRETORY PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL VIABILITY; COILED BODY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; APOPTOSIS; BCL-X PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; CLUSTERIN; HEK293 CELLS; HUMANS; KERATINOCYTES; MALE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY;

EID: 84155184197     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22836     Document Type: Article

References (51)

1. Balantinou E, Trougakos IP, Chondrogianni N, Margaritis LH, Gonos ES. 2009. Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways. Free Radic Biol Med 46: 1267-1274.
2. Bettuzzi S, Davalli P, Davoli S, Chayka O, Rizzi F, Belloni L, Pellacani D, Fregni G, Astancolle S, Fassan M, Corti A, Baffa R, Sala A. 2009. Genetic inactivation of ApoJ/clusterin: Effects on prostate tumourigenesis and metastatic spread. Oncogene 28: 4344-4352.
3. Burkey BF, deSilva HV, Harmony JA. 1991. Intracellular processing of apolipoprotein J precursor to the mature heterodimer. J Lipid Res 32: 1039-1048.
4. Bursch W, Karwan A, Mayer M, Dornetshuber J, Frohwein U, Schulte-Hermann R, Fazi B, Di Sano F, Piredda L, Piacentini M, Petrovski G, Fesus L, Gerner C. 2008. Cell death and autophagy: Cytokines, drugs, and nutritional factors. Toxicology 254: 147-157.
5. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. 2001. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705-711.
6. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. 2010. The BCL-2 family reunion. Mol Cell 37: 299-310.
7. Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R, Ploegh H, Kessler BM, Sinclair DA. 2004. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13: 627-638.
8. Cole C, Barber JD, Barton GJ. 2008. The Jpred 3 secondary structure prediction server. Nucleic Acids Res 36: W197-W201.
9. Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC, Fairlie WD, Hinds MG, Colman PM. 2007. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 104: 6217-6222.
10. Day CL, Chen L, Richardson SJ, Harrison PJ, Huang DC, Hinds MG. 2005. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J Biol Chem 280: 4738-4744.
11. Day CL, Smits C, Fan FC, Lee EF, Fairlie WD, Hinds MG. 2008. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J Mol Biol 380: 958-971.
12. Debure L, Vayssiere JL, Rincheval V, Loison F, Le Drean Y, Michel D. 2003. Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration. J Cell Sci 116: 3109-3121.
13. Dia VP, Mejia EG. 2010. Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression. Cancer Lett 295: 44-53.
14. Eddy SR. 1998. Profile hidden Markov models. Bioinformatics 14: 755-763.
15. Essabbani A, Margottin-Goguet F, Chiocchia G. 2010. Identification of clusterin domain involved in NF-kappaB pathway regulation. J Biol Chem 285: 4273-4277.
16. Han BH, DeMattos RB, Dugan LL, Kim-Han JS, Brendza RP, Fryer JD, Kierson M, Cirrito J, Quick K, Harmony JA, Aronow BJ, Holtzman DM. 2001. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 7: 338-343.
17. Jurisic V, Bogdanovic G, Srdic T, Jakimov D, Mrdjanovic J, Baltic M, Baltic VV. 2004. Modulation of TNF-alpha activity in tumor PC cells using anti-CD45 and anti-CD95 monoclonal antibodies. Cancer Lett 214: 55-61.
18. Jurisic V, Bogdanovic G, Kojic V, Jakimov D, Srdic T. 2006. Effect of TNF-alpha on Raji cells at different cellular levels estimated by various methods. Ann Hematol 85: 86-94.
19. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. 2006. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358.
20. Kim I, Xu W, Reed JC. 2008. Cell death and endoplasmic reticulum stress: Disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7: 1013-1030.
21. Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. 2009. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell 36: 487-499.
22. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD. 2002. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331-342.
23. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR, Newmeyer DD. 2005. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17: 525-535.
24. Lanave C, Santamaria M, Saccone C. 2004. Comparative genomics: The evolutionary history of the Bcl-2 family. Gene 333: 71-79.
25. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. 2003. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 278: 11590-11600.
26. Liu Z, Lu H, Jiang Z, Pastuszyn A, Hu CA. 2005. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol Cancer Res 3: 21-31.
27. Marcelli M, Marani M, Li X, Sturgis L, Haidacher SJ, Trial JA, Mannucci R, Nicoletti I, Denner L. 2000. Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation. Prostate 42: 260-273.
28. Markopoulou S, Kontargiris E, Batsi C, Tzavaras T, Trougakos I, Boothman DA, Gonos ES, Kolettas E. 2009. Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumulation of clusterin. FEBS J 276: 3784-3799.
29. Moretti RM, Marelli MM, Mai S, Cariboni A, Scaltriti M, Bettuzzi S, Limonta P. 2007. Clusterin isoforms differentially affect growth and motility of prostate cells: Possible implications in prostate tumorigenesis. Cancer Res 67: 10325-10333.
30. Oberstein A, Jeffrey PD, Shi Y. 2007. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282: 13123-13132.
31. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH. 2005. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677-681.
32. O'Sullivan J, Whyte L, Drake J, Tenniswood M. 2003. Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ 10: 914-927.
33. Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, Mack J, Swift K, Matayoshi ED, Zhang H, Thompson CB, Fesik SW. 2000. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci 9: 2528-2534.
34. Petros AM, Olejniczak ET, Fesik SW. 2004. Structural biology of the Bcl-2 family of proteins. Biochim Biophys Acta 1644: 83-94.
35. Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG. 2004. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23: 2298-2304.
36. Rizzi F, Caccamo AE, Belloni L, Bettuzzi S. 2009. Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells. J Cell Physiol 219: 314-323.
37. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB, Fesik SW. 1997. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 275: 983-986.
38. Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S. 2004. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1. Cancer Res 64: 6174-6182.
39. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J. 2006. Challenge and promise: Roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13: 12-19.
40. Takase O, Minto AW, Puri TS, Cunningham PN, Jacob A, Hayashi M, Quigg RJ. 2008. Inhibition of NF-kappaB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis. Kidney Int 73: 567-577.
41. Trougakos IP, Gonos ES. 2004. Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress. Ann NY Acad Sci 1019: 206-210.
42. Trougakos IP, Djeu JY, Gonos ES, Boothman DA. 2009a. Advances and challenges in basic and translational research on clusterin. Cancer Res 69: 403-406.
43. Trougakos IP, Lourda M, Antonelou MH, Kletsas D, Gorgoulis VG, Papassideri IS, Zou Y, Margaritis LH, Boothman DA, Gonos ES. 2009b. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin Cancer Res 15: 48-59.
44. van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, Adams JM, Roberts AW, Huang DC. 2006. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10: 389-399.
45. Wehrli P, Charnay Y, Vallet P, Zhu G, Harmony J, Aronow B, Tschopp J, Bouras C, Viard-Leveugle I, French LE, Giannakopoulos P. 2001. Inhibition of post-ischemic brain injury by clusterin overexpression. Nat Med 7: 977-979.
46. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P, Strasser A, Kluck RM, Adams JM, Huang DC. 2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315: 856-859.
47. Yang CR, Yeh S, Leskov K, Odegaard E, Hsu HL, Chang C, Kinsella TJ, Chen DJ, Boothman DA. 1999. Isolation of Ku70-binding proteins (KUBs). Nucleic Acids Res 27: 2165-2174.
48. Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA. 2000. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Natl Acad Sci USA 97: 5907-5912.
49. Youle RJ, Strasser A. 2008. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59.
50. Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY. 2005. Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7: 909-915.
51. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. 2001. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 15: 1481-1486.